Sandoz - Product http://www.alloftv.com/media-release-topics/product en Sandoz extends SYMJEPI? (epinephrine) Injection launch to US pharmacies to help improve patient access to life-saving medicine http://www.alloftv.com/news/media-releases/sandoz-extends-symjepi-epinephrine-injection-launch-us-pharmacies-help-improve Tue, 09 Jul 2019 12:21:55 +0000 singema2 21931 at http://www.alloftv.com Sandoz launches oncology generic gefitinib in 13 EU countries at loss of market exclusivity, expanding access to essential medicine http://www.alloftv.com/news/media-releases/sandoz-launches-oncology-generic-gefitinib-13-eu-countries-loss-market Tue, 02 Jul 2019 06:38:28 +0000 singema2 21911 at http://www.alloftv.com Sandoz demonstrates strategic focus on China, with first-of-a-kind generic approval under Quality Consistency Evaluation system http://www.alloftv.com/news/media-releases/sandoz-demonstrates-strategic-focus-china-first-kind-generic-approval-under Thu, 09 May 2019 05:33:30 +0000 singema2 21886 at http://www.alloftv.com Sandoz resubmits biosimilar pegfilgrastim application to US FDA http://www.alloftv.com/news/media-releases/sandoz-resubmits-biosimilar-pegfilgrastim-application-us-fda Tue, 02 Apr 2019 14:11:05 +0000 singema2 21866 at http://www.alloftv.com Sandoz Inc. launches SYMJEPI? (epinephrine) in the US http://www.alloftv.com/news/media-releases/sandoz-inc-launches-symjepi-epinephrine-us Thu, 17 Jan 2019 08:28:03 +0000 singema2 21836 at http://www.alloftv.com Sandoz signs agreement with Pear Therapeutics to develop and commercialize prescription digital therapeutics for patients with substance use disorder and opioid use disorders http://www.alloftv.com/news/media-releases/sandoz-signs-agreement-pear-therapeutics-develop-and-commercialize-prescription Mon, 16 Apr 2018 11:31:21 +0000 singema2 21461 at http://www.alloftv.com Sandoz receives positive CHMP opinion for proposed biosimilar infliximab http://www.alloftv.com/news/media-releases/sandoz-receives-positive-chmp-opinion-proposed-biosimilar-infliximab Thu, 22 Mar 2018 08:41:42 +0000 singema2 21416 at http://www.alloftv.com Sandoz announces US FDA approval and launch of Glatopa? 40 mg/mL three times-a-week generic option for relapsing forms of multiple sclerosis http://www.alloftv.com/news/media-releases/sandoz-announces-us-fda-approval-and-launch-glatopar-40-mgml-three-times-week Tue, 13 Feb 2018 06:23:08 +0000 singema2 21401 at http://www.alloftv.com Sandoz proposed biosimilar pegfilgrastim accepted by EMA for regulatory review http://www.alloftv.com/news/media-releases/sandoz-proposed-biosimilar-pegfilgrastim-accepted-ema-regulatory-review Wed, 25 Oct 2017 07:35:03 +0000 singema2 21291 at http://www.alloftv.com Sandoz proposed biosimilar adalimumab matches reference biologic in terms of efficacy and safety in long-term study http://www.alloftv.com/news/media-releases/sandoz-proposed-biosimilar-adalimumab-matches-reference-biologic-terms-efficacy Wed, 13 Sep 2017 11:09:20 +0000 singema2 21201 at http://www.alloftv.com 92午夜免费福利757-丝袜美腿